Responses

Download PDFPDF
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Corticosteroid side effects

    Dear Editor,

    The excellent review by da Silva and colleagues (1) comprehensively covers the range of glucocorticoid side effects and points out that more research in this area is sorely needed. One area they don�t review and which we have previously suggested should be considered as an adverse effect (2) is that the use of steroids by both primary doctors and rheumatologists so frequently preempts the use of...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Low-dose glucocorticoid treatment in Rheumatoid Arthritis: Is it safe? Is it effective?

    Dear Editor,

    A recent review was published in Annals (1) which assessed the safety of low dose glucocorticoid (GC) treatment in rheumatoid arthritis (RA), relying heavily on the results of four small randomized controlled trials. The summary of this review stated “Safety data from recent randomized controlled clinical trials of low dose glucocorticoid treatment in RA suggest that adverse effects associated with thi...

    Show More
    Conflict of Interest:
    None declared.